Status:
COMPLETED
Evaluation, Treatment, and Training for Patients With Blood Disorders
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Hematologic Diseases
Eligibility:
All Genders
2-110 years
Brief Summary
This study is designed to allow the evaluation, follow-up, and medical care of patients with blood disorders not currently participating in a research study being conducted by the Hematology Branch of...
Detailed Description
This protocol is designed to allow the evaluation, follow up, and standard medical care of patients (and when appropriate, their stem cell donor) with bone marrow failure states, cytopenias, metastati...
Eligibility Criteria
- INCLUSION CRITERIA:
Patients (and when appropriate the patient's stem cell donor) may be entered on this protocol at the discretion of the Principal and/or Associate Investigators if :
An investigator decides that it is in the best interest of the patient/donor and the Branch for the patient to be enrolled in this protocol while awaiting a decision on eligibility for other protocols; or after enrollment on another protocol, or to allow careful evaluation of patients with unique or rare disorders of direct interest to the Branch; or with more common disorders for fellowship teaching purposes.
The patient or the patient's guardian is capable of informed consent and signs the consent form. The consent form will be signed by parents or guardians of patients under the age of 18.
Age greater than or equal to 2 and weight greater than 12 kg.
Key Trial Info
Start Date :
November 8 1993
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 5 2020
Estimated Enrollment :
1452 Patients enrolled
Trial Details
Trial ID
NCT00001397
Start Date
November 8 1993
End Date
October 5 2020
Last Update
October 8 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892